Showing results (1241-1250 of 1,482) with videos related to
Sort By:
Pageof 149
Human Psychopharmacology|July 26, 2021
A systematic review of (pre)clinical studies on the therapeutic potential and safety profile of kratom in humansElisabeth Prevete, Kim Paula Colette Kuypers, Eef Lien Theunissen, et al.Human Psychopharmacology|December 22, 2017
Psychiatrists' treatment preferences for generalized anxiety disorderMilan Latas, Goran Trajković, Dimitar Bonevski, et al.Human Psychopharmacology|October 9, 2003
Donepezil in a chronic drug user--a potential treatment?Diana Jovanovski, Konstantine K ZakzanisHuman Psychopharmacology|October 9, 2003
Induction of mania in depression by paroxetineShigeru Morishita, Seizaburo AritaHuman Psychopharmacology|January 13, 2004
Switching to quetiapine in patients with acute mania who were intolerant to risperidoneChi-Un Pae, Kyong-Uk Lee, Jung-Jin Kim, et al.Human Psychopharmacology|December 30, 2003
Comparative study of acute effects of single doses of fexofenadine, olopatadine, d-chlorpheniramine and placebo on psychomotor function in healthy volunteersHiroyuki Kamei, Yukihiro Noda, Kazuhiro Ishikawa, et al.Human Psychopharmacology|December 30, 2003
Reduced short-term obsessive-compulsive symptoms in schizophrenic patients treated with risperidone: a single-blind prospective studyBaybars Veznedaroglu, Eyup Sabri Ercan, Bulent Kayahan, et al.Human Psychopharmacology|October 9, 2003
Effect of pindolol and milnacipran versus milnacipran and placebo on plasma prolactin and adrenocorticotrophic hormone in depressed subjectsMaria B Isaac, Michael T IsaacHuman Psychopharmacology|May 19, 2017
New psychoactive substances: Purchasing and supply patterns in AustraliaRachel Sutherland, Raimondo Bruno, Amy Peacock, et al.Human Psychopharmacology|May 10, 2017
L-carnosine as an adjuvant to fluvoxamine in treatment of obsessive compulsive disorder: A randomized double-blind studySomaye Arabzadeh, Maryam Shahhossenie, Bita Mesgarpour, et al.Pageof 149